Biotech

All Articles

2 cancer biotechs merge, generating global footprint

.OncoC4 is taking AcroImmune-- as well as its own internal professional production functionalities--...

Amgen reports 1st phase 3 win for $400M eczema drug

.Amgen has actually discussed (PDF) the 1st period 3 data on its $400 million eczema medication, con...

Biogen, UCB record period 3 lupus win after stopping working earlier test

.Biogen and UCB's depend developing in to stage 3 on the back of a broken study looks to have actual...

Aptadir really hopes brand new RNA preventions can easily turn around complicated cancers cells

.Italian biotech Aptadir Rehabs has launched with the pledge that its own pipeline of preclinical RN...

Wave surfs DMD results to regulators' doors, sending stockpile

.Wave Lifestyle Sciences has actually satisfied its own objective in a Duchenne muscle dystrophy (DM...

Sanofi picks brand-new CSO coming from in-stealth biotech

.After a couple of years in biotech, Mike Quigley, Ph.D., is coming back to the pharma crease, using...